Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>Abingdon Health 7.75p £18.20m (ABDX.L) The international developer, manufacturer, and distributor of high quality and effective rapid tests announces a new contract win with an expected value of approximately US$2m.</li>
<li>The Company has signed a Master Service Agreement (MSA) with a US-based company for the development and scale up to manufacture of a semi-quantitative, multiplex lateral flow test system.</li>
<li>The MSA covers the feasibility, optimisation, scale-up, and technical transfer to manufacturing of the test for multiple analytes. </li>
</ul>


Abingdon Health 7.75p £18.20m (ABDX.L) The international developer, manufacturer, and distributor of high quality and effective rapid tests announces a new contract win with an expected value of approximately US$2m.
The Company has signed a Master Service Agreement (MSA) with a US-based company for the development and scale up to manufacture of a semi-quantitative, multiplex lateral flow test system.
The MSA covers the feasibility, optimisation, scale-up, and technical transfer to manufacturing of the test for multiple analytes. 


Hybridan Small Cap Feast: 10 November 2025